chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Office Visit 3/19/2021  MD Suspected COVID-19 virus infection +3 more Dx URI sxs  Reason for Visit Progress Notes  MD (Physician) Encounter Date: 3/19/2021 ? ? Addendum Expand AllCollapse All      Assessment/Plan      Patient was seen today for uri sxs.   Diagnoses and all orders for this visit:   Suspected COVID-19 virus infection -     COVID-19 PCR -     COVID-19 (SARS CoV-2,RNA Molecular Amplification)   Cough   Fever, unspecified fever cause   Mild intermittent asthma with acute exacerbation   Other orders -     levalbuterol (XOPENEX HFA) 45 mcg/actuation inhaler; Inhale 2 puffs every 4 (four) hours as needed  for wheezing
Hives. Took over the counter antihistamines for two to three weeks.  Didn?t think it was vaccine related but my daughter also got hives 2 weeks after vaccination. Neither of us had ever had hives before.
PRODUCT STORAGE ERROR; VACCINE WAS ADMINISTERED TO PATIENT DIRECTLY FROM THE FREEZER WITHOUT BEING STORED AT RECOMMENDED STORAGE CONDITIONS OF 2 TO 8 CELSIUS; This spontaneous report received from a health care professional concerned a 41 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, expiry: UNKNOWN) dose was not reported, administered on 28-MAR-2022 for prophylactic vaccination. Age at time of vaccination 41 years old. No concomitant medications were reported.  On 28-MAR-2022, the patient experienced vaccine was administered to patient directly from the freezer without being stored at recommended storage conditions of 2 to 8 celsius. On an unspecified date, the patient experienced product storage error. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the product storage error and vaccine was administered to patient directly from the freezer without being stored at recommended storage conditions of 2 to 8 celsius was not reported. This report was non-serious. This case, from the same reporter is linked to 20220504995, 20220505044, 20220505162, 20220505192, 20220505373, 20220505593 and 20220505824.
Developed nausea and vomiting after her COVID vaccine earlier today. Associated with chills and tremors. These improved 45 minutes ago.    Poor PO intake. No abdominal pain.  COVID, flu negative. Mild systemic vaccine reaction. Zofran given and rx. Advised patient to speak with her PCP before considering second COVID vaccine.
From faxed correspondence received at manufacturer on 10/07/02, it was reported that a 31 year old female received Fluzone SV 2002-2003 USP vaccine (Lot # E31882CA) in the left arm and pneumonia vaccine (manufacturer Merck, Lot # 0165M) in the left arm on 10/02/03.  She reportedly developed a swelling of the left arm, painful and warm to touch. She applied an ice pack 10 minutes on and 15 minutes off, and was advised to call physician to order antihistamines.  It was not reported whether the pt recovered.  See case # U2002-00952 with the same reporter.
After 3/18/21 second covid vaccine I developed body aches 12 hours later; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Mar2021 09:30 (Lot number: EN6203) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Chronic migraines" (unspecified if ongoing); "Osteoarthritis" (unspecified if ongoing). Concomitant medication(s) included: SHINGRIX, start date: 09Feb2021; ADVIL; RELPAX. Vaccination history included: Bnt162b2 (Dose number: 1, lot number: EL3247, administration date:25Feb2021, administration time:09:30 AM, vaccine location:Left arm), administration date: 25Feb2021, for Covid-19 immunization. The following information was reported: PAIN (non-serious) with onset 18Mar2021 21:30, outcome "recovering", described as "After 3/18/21 second covid vaccine I developed body aches 12 hours later"; CHILLS (non-serious) with onset 18Mar2021 21:30, outcome "recovering", described as "Chills". Therapeutic measures were not taken as a result of pain, chills.  Additional information: The patient reported that 24 hours post vaccine, still have body aches, but not as strong as during the night. The facility where the most recent COVID-19 vaccine was administered is Workplace clinic. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food, or other products.  No follow-up attempts are possible. No further information is expected.
extreme allergic reaction starting on upperback, then lower, then thighs, legs given given a low dose steroid pills very itchy
Patient developed small shingles rash on her back. Went to her physician and we dispensed a prescription for Valtrex to treat.
High blood pressure; sore arm (left); This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (High blood pressure) and ARTHRALGIA (sore arm (left)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included FISH OIL, CALCIUM, VITAMIN C [ASCORBIC ACID] and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced ARTHRALGIA (sore arm (left)). On 30-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (High blood pressure). On 29-Jan-2021, ARTHRALGIA (sore arm (left)) had resolved. On 30-Jan-2021, BLOOD PRESSURE INCREASED (High blood pressure) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Correspondence email attached & In form the event outcome updated; Reporter's Comments: The events were consistent with increased risk of complications associated with hypertension confounded by elderly age of patient. Company assessed the events to be unlikely related to company product.; Sender's Comments: Spoke with the patient and she said that the anti-inflammatory medication that her doctor prescribed raised her blood pressure (BP) and it wasn't due to the shot. Her BP is fine now. The sore arm was really nothing, the reaction was very mild. She feels fine now.
Swelling and pain at injection site.; Swelling and pain at injection site.; This is a spontaneous report from a contactable consumer (patient). A 29-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EM9810), via an unspecified route of administration, administered in Arm Left on 06Feb2021 14:30 (at the age of 29-year-old) as dose 1, single for covid-19 immunisation. Medical history included hypothyroidism and allergy to adhesive in band aids. Concomitant medication(s) included spironolactone (ALDACTONE) taken for an unspecified indication, start and stop date were not reported, citalopram taken for an unspecified indication, start and stop date were not reported, levothyroxine taken for an unspecified indication, start and stop date were not reported, retinol acetate (VITAMIN A) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine in four weeks. Other medications in two weeks included Aldactone, citalompram, levothyroxine, vit. A. The patient experienced swelling and pain at injection site on 15Feb2021 at 12:00AM. Symptoms started Monday the 15th, 10 days after the injection. Patient did not have covid prior vaccination and covid was not tested post vaccination. Patient did not receive treatment for adverse events. The outcome of swelling and pain at injection site was recovering.   Follow-up attempts completed. No further information expected.
Headache - I had some neck pain. I don't remember - I might have some dizziness - I put them on the v-safe check-ins. I had to be taken by ambulance to the hospital on 4/17/2021 - I thought I was having a stroke. They said that I had developed bells palsy on the right side of my face. They gave me medication to use for one week. The symptoms that I was having went away less than two weeks later. They told me that Bells Palsy symptoms could last two weeks to six months. It's gone right now - I don't see any symptoms of it.  I did have a virtual appt appt with my doctor -
Flu shot of September 19th in the morning at my employer. Shoulder pain starting day after, was unable to raise my left arm and limited movement in my left shoulder without experiencing pain. Had a Dr appointment on Oct 23rd to see if the shoulder pain was related to my previous sore neck. Neck has mild spinal stenosis. Dr. examined and said the location of the neck spinal stenosis would not affect my shoulder. Referred me to see an Orthopedic. Made an appointment with Dr. Xray were completed and examination. Small tear in my left rotator cuff, cortisone injection was given. Provided relief for a few weeks.
Patient experienced dizziness, weakness, nausea, and pale skin after receiving her 1st COVID vaccine.
Report fever of 101.2, chills, HA began next day after vaccination. Treatment: Tylenol with improvement of HA and chills and fever resolved. Outcome: Does not interfere with ADLs.
Observed pt with symptoms of flushing, feeling hot, tingling feeling, felt like her HR was faster.  Water, Observed for a total of 45 min. Felt the same but was okay.  No worsening.  Pulse Ox 97%, HR 77 .
pt recv vax & c/o rash, tachycardia, tingling, HTN, anxiety;
Information has been received from a physician concerning a 4-month- old male who was vaccinated PO with a 2.0 mL dose ROTATEQ vaccine. The physician reported that the patient subsequently developed excessive diarrhea. Unspecified medical attention was sought. The day after onset, the patient's diarrhea resolved. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 11/14/2006. Follow-up information from a physician's assistant indicated that she could only remember that either a 2 or 4 month old male was vaccinated with a dose of ROTATEQ vaccine, and then less than 24 hours after the dose the patient developed diarrhea. It was reported that the patient's mother did not want the infant to receive the next dose because of the diarrhea. Additional information is not expected.
Menstrual cycle stopped after my first dose. My first dose was august 5th my 2nd august 26. Had a normal period in July and haven?t had one since. Multiple negative pregnancy tests.
The patient had a sore arm and inability to raise it. She iced it and used ibuprofen. The next day the arm became swollen, red and hot to the touch from the administration site to the elbow with a burning type pain. The patient continued to ice, used Benadryl and loratadine and over the course of the next few days the reaction dissipated.
Child ran fever up to 103.8. Pt had seizure activity lasting less than 1 minute. Pt. seen in ER.
Pt. received shot in (L) arm. States within an hr it started to hurt. States her (L) shoulder ached constantly for 2 wks. States she still can't lift (L) arm up over her head. C/o (L) arm going to sleep at times.
patient received a dose of MMR II that was reconstituted with "sodium chloride or sterile water" instead of the Merck supplied diluent.; No adverse effects were reported; This spontaneous report has been received from pharmacist referring a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, (recombinant human albumin (rHA)(M-M-R II) subcutaneous injection, lot number U031359 that had been verified to be a valid number with expiration date 07-OCT-2023, administered for prophylaxis (strength, specific dosage, vaccination scheme, route of administration and anatomical site of application were not provided) that was reconstituted with an unspecified brand of "sodium chloride or sterile water" instead of the Merck supplied diluent (product preparation error). No adverse effects were reported  This case was classified as non-valid due to lack of patient identifiers.  Follow-up information has been received from the pharmacist on 30-MAR-2023 referring an approximately 31-year-old male patient.  On 12-FEB-2023, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, (recombinant human albumin (rHA)(M-M-R II) subcutaneous injection, lot number U031359 that had been verified to be a valid number with expiration date 07-OCT-2023 (also reported as 6024220), administered subcutaneously in a left limb (strength, specific dosage, and vaccination scheme, were not provided). The patient was contacted several times and no answer was received.    This case was considered valid as patient identifiers were provided.
A Pfizer pediatric  first dose was administered without a diluent on 01/31/2022. The pharmacy on duty followed up with the patient's mother if the patient experienced any possible side effects and the mother said that the patient is doing okay. She did not experienced side effects and went to school.
Resident had a fall.  Went to the hospital where he tested positive, on a screen, for covid.  Had been asymptomatic
L thigh is red, warm to touch with induration 7 1/2" X 5".
64 y female with h/o AVNRT, vision impairment, s/p zoster vaccine sub-Q near left triceps and flu vaccine IM in left deltoid region on 11/20/15, presenting with progressive redness, tenderness and warmth around injection sites, likely zoster site. Symptoms mostly local around injection site but itchy palms and itchy throat concerning for a more systemic hypersensitivity reaction -> no stridor, wheezing, fevers or other mucosal involvement. Erythema and timing of it starting 3hrs after injection more suggestive of reaction rather than infection. Likely zoster but cannot rule out reaction to influenza. Pt has tolerated flu vaccine in past but cannot be sure based on injection notes the exact sites of each injection. Pt responded well to BENADRYL, SOLU-MEDROL and ranitidine in ER. Diphenhydramine 25 mg once, methylprednisolone 125 mg once, ranitidine 50 mg once.
1/19/22 pt to SNF for PT/OT after recent hospitalization for encephalopathy, hypoxic respiratory failure and hypertensive urgency; in SNF pt is total care; poor appetite; DNR; comfort measures only; no artificial nutritional feeding; pt had a positive COVID test on 2/1/22 and passed away in the SNF
she had fever 24 hours after the 2nd dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 79 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1), for Covid-19 immunisation. The following information was reported: PYREXIA (non-serious), outcome "recovered", described as "she had fever 24 hours after the 2nd dose". Therapeutic measures were taken as a result of pyrexia.  Additional information: The patient took tylenol as a treatment for adverse event (But when she took Tylenol, she felt fine)  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This am leg was warn with hard spot. Since then seems to be more swollen with some reddness.
Pain started above eyebrow 7 days after vaccine, diagnosed a few days later at urgent care and er. Shingles on the left side of the face, surrounding the eye.  Currently on valtrex
Injection site hot; Injection site redness; Injection site swelling; Injection site painful; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site painful). At the time of the report, VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.  Company Comment: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded; Sender's Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded
Psoriasis flare-up; This spontaneous case was reported by a non-health professional and describes the occurrence of PSORIASIS (Psoriasis flare-up) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PSORIASIS (Psoriasis flare-up). At the time of the report, PSORIASIS (Psoriasis flare-up) outcome was unknown.            No concomitant medication provided. No treatment information mentioned.  The patient got the covid vaccine five days before injecting Skyrizi and experienced a psoriasis flare and that her skin had not cleared since.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
Hospitalized for COVID, weakness, ambulatory dysfunction 12/8/21-12/10/21. Treated with vitamin C 1,000 mg daily, vitamin D 1,000 units daily, zinc 220 mg daily.
Sever GI disorder following  vaccination, which is listed  as a "rare" side effect. Vomiting up feeds, blood in stools. Excessive crying. Since has been determined he has severe food allergies now
Patient had received her 1st GARDASIL injection.  While receiving return visit instructions, patient fainted, hitting her head L elbow & L knee.  Attended by staff & MD.  Vital signs WNL, examined by MD & given po fluids prior to discharge home.
On the afternoon of Tuesday, Sept 7, 2021, 10 days after my second dose of the COVID vaccine, I started feeling dizzy, nausea, slurred speech, was taken to ER by ambulance, cat scan was done and a blood clot was found at the base of the brain stem.  Was given tPA  and admitted into the hospital.  I was diagnosed as having a stroke.  I was in the hospital for 2 weeks, for observation and therapy.  I was discharged on Sept 21 and currently continuing  outpatient, physical and occupational therapy.  The stroke effected my balance and have double vision.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. On an unknown dates, the patients was vaccinated with improperly stored doses of PEDVAXHIB, ROTATEQ and sterile diluent (dose, lot #, expiration date were not reported). No adverse event was reported. Administered doses of vaccines experienced the temperature excursion of 48.7 degrees Fahrenheit for 1 hour 30 minutes. Data logger was involved. There were no previous excursions reported. Additional information has been requested.
hematoma at Bx site of injection 10cm x 10cm improving d-dimer ordered to r/o DVT pt with hx of cirrhosis & cbc to evaluate platelet count
Redness and swelling at injection site started day after injection and increased in size till 09/07. On 9/8 redness measured 21x25 mm.
Chills; fever; confusion; vomiting; diarrhea; insomnia; could not get out of bed; low energy; intense headache; shoulders and neck muscles very tight; spasming level 10 bone pain; spasming level 10 bone pain; dehydration from vomiting; exhaustion & fatigue from illness; My right arm continues to be very sore; I also have blisters in my mouth and my gums are very inflamed; This is a spontaneous report from a contactable consumer (patient). A 64-years-old non-pregnant female patient received second dose of BNT162b2 (COMIRNATY, Solution for injection, Lot Number: EN6205), via an unspecified route of administration, administered in right arm on 03Mar2021 at 12:45 (at the age of 64 years), as dose 2, single for COVID-19 immunisation. Medical history included contrast dye allergy from an unknown date. The patient did not receive any other drugs within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since having the vaccine. The patient previously took Tylenol, morphine, codeine, percocet and had allergy to drug. The patient previously received first dose of BNT162b2 (COMIRNATY, Solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in left arm on 12Feb2021 at 12:00 (at the age of 64 years), as dose 1, single for COVID-19 immunisation. On 03Mar2021 at 23:00, the patient experienced Chills, fever, confusion, vomiting, diarrhea, insomnia, could not get out of bed, low energy, intense headache, shoulders and neck muscles very tight and spasming level 10 bone pain, dehydration from vomiting, exhaustion & fatigue from illness and lack of sleep. Patient also have blisters in her mouth and her gums are very inflamed, this continues to today, 08Mar2021. Headache and low energy lasted through Saturday, 06Mar2021. Patient right arm continues to be very sore. Patient have only been this violently ill one other time in my life and that was with the flu when she was 17 years old. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment was given for the events. The outcome of all the events was recovered on an unspecified date in 2021.   No follow-up attempts are possible. No further information is expected.
Patient became faint after vaccine and had syncopal episode when walking to cot. treatment: not indicated outcomes: evaluated by EMS, vitals stable and patient recovered